dr tarantino on the safety of t-dxd and t-dm1 in her2 breast cancer
Published 1 month ago • 50 plays • Length 2:41Download video MP4
Download video MP3
Similar videos
-
2:02
dr tarantino on updated survival data with t-dxd in her2 breast cancer
-
1:08
updated survival results of destiny-breast03: t-dxd vs t-dm1 in her2 metastatic breast cancer
-
9:38
role of t-dm1 in her2-positive metastatic breast cancer
-
0:57
dr. louis weiner on the t-dm1 mechanism of action in her2-positive breast cancer
-
1:20
updated results of destiny-breast03: t-dxd vs t-dm1 in metastatic her2 breast cancer
-
0:48
evaluating the safety of t-dxd with radiotherapy in her2 metastatic breast cancer
-
2:48
destiny-breast03: t-dxd is superior to t-dm1 in her2 metastatic breast cancer
-
1:08
destiny-breast02: t-dxd in her2 metastatic breast cancer previously treated with t-dm1
-
0:58
comparing and sequencing t-dm1 and t-dxd in her2 breast cancer
-
0:53
tuxedo-1: t-dxd for patients with her2-positive breast cancer and brain metastasis
-
0:56
destiny-breast04: t-dxd for patients with her2-low mbc
-
4:01
trastuzumab deruxtecan: a promising agent for treating her2-low breast cancer?
-
0:48
highlights from esmo: destiny-breast03
-
3:15
dr curigliano on the efficacy of t-dxd in her2-low and her2-ultralow breast cancer
-
1:46
choosing between tucatinib and t-dxd in her2 breast cancer
-
7:12
t-dxd demonstrates high levels of efficacy in patients with her2 unresectable and/or mbc previo...
-
3:09
destiny-breast02: high levels of efficacy of t-dxd in previously treated her2 breast cancer
-
6:51
adcs for her2 and her2-low breast cancer
-
1:40
dr. demichele on the i-spy2 trial for her2 breast cancer